Author:
Nitti D.,Wils J.,Dos Santos J. Guimaraes,Fountzilas G.,Conte P.F.,Sava C.,Tres A.,Coombes R.C.,Crivellari D.,Marchet A.,Sanchez E.,Bliss J.M.,Homewood J.,Couvreur M.L.,Hall E.,Baron B.,Woods E.,Emson M.,Van Cutsem E.,Lise M.
Reference24 articles.
1. Relevant prognostic factors in gastric cancer. Ten-year results of the German gastric cancer study;Siewert;Ann Surg,1998
2. Gastric carcinoma: does lymph node dissection alter the survival?;Wanebo;J Am Coll Surg,1996
3. Clinicopathologic characteristics and prognostic factors in 10783 patients with gastric cancer;Kim;Gastric Cancer,1998
4. Sequential high-dose methotrexate and fluorouracil combined with doxorubicin—a step ahead in the treatment of advanced gastric cancer: a trial of the European Organization for Research and Treatment of Cancer, Gastrointestinal Tract Cooperative Group;Wils;J Clin Oncol,1991
5. Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophago-gastric cancer;Webb;J Clin Oncol,1997
Cited by
81 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献